![]() Oxidopamine hydrochloride structure
|
Common Name | Oxidopamine hydrochloride | ||
---|---|---|---|---|
CAS Number | 28094-15-7 | Molecular Weight | 205.63900 | |
Density | N/A | Boiling Point | 406ºC at 760 mmHg | |
Molecular Formula | C8H12ClNO3 | Melting Point | 232-233ºC (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 199.3ºC | |
Symbol |
![]() GHS07 |
Signal Word | Warning |
Use of Oxidopamine hydrochlorideOxidopamine hydrochloride is a neurotoxic synthetic organic compound, selectively destroys dopaminergic and noradrenergic neurons in the brain. |
Name | 6-Hydroxy Dopamine Hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Oxidopamine hydrochloride is a neurotoxic synthetic organic compound, selectively destroys dopaminergic and noradrenergic neurons in the brain. |
---|---|
Related Catalog |
Boiling Point | 406ºC at 760 mmHg |
---|---|
Melting Point | 232-233ºC (dec.)(lit.) |
Molecular Formula | C8H12ClNO3 |
Molecular Weight | 205.63900 |
Flash Point | 199.3ºC |
Exact Mass | 205.05100 |
PSA | 86.71000 |
LogP | 1.80690 |
Vapour Pressure | 3.58E-07mmHg at 25°C |
Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
RIDADR | NONH for all modes of transport |
RTECS | DC4650000 |
Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.
Brain Behav. 3(2) , 75-88, (2013) Cerebral dopamine neurotrophic factor (CDNF) protein has been shown to protect the nigrostriatal dopaminergic pathway when given as intrastriatal infusions in rat and mouse models of Parkinson's disea... |
|
Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration.
PLoS ONE 10 , e0136620, (2015) ERp57 (also known as grp58 and PDIA3) is a protein disulfide isomerase that catalyzes disulfide bonds formation of glycoproteins as part of the calnexin and calreticulin cycle. ERp57 is markedly upreg... |
|
LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Neurol. Sci. 36 , 2027-33, (2015) Lysophosphatidic acid (LPA) is a bioactive phospholipid that activates at least five known G-protein-coupled receptors (GPCRs): LPA1-LPA5. The nervous system is a major locus for LPA1 expression. LPA ... |
6-Hydroxydopamine hydrochloride |
6-HYDROXYDOPAMINE HYDROCHLORIDE |
5-(2-Aminoethyl)benzene-1,2,4-triol hydrochloride |
Oxidopamine (hydrochloride) |